A clinical pathway for bronchiolitis is effective in reducing readmission rates

Area of Science:

• Pediatrics
• Clinical Management
• Public Health

Background:

• Acute viral bronchiolitis is a common respiratory infection in infants.
• Current management strategies vary, potentially leading to inconsistent care and suboptimal outcomes.
• Standardized care protocols are needed to optimize treatment and reduce healthcare resource utilization.

Purpose of the Study:

• To evaluate the effectiveness of a clinical pathway in managing infants hospitalized with acute viral bronchiolitis.
• To compare outcomes between infants managed with a clinical pathway versus standard care.
• To assess the impact of a clinical pathway on readmission rates, treatment administration, and discharge planning.

Main Methods:

• A prospective cohort study comparing 229 infants managed with a clinical pathway to 207 infants managed retrospectively without a pathway.
• The clinical pathway included specific management and discharge criteria adapted from tertiary care institutions.
• Data were collected from 3 regional and 1 tertiary care hospital.

Main Results:

• The clinical pathway group demonstrated significantly lower hospital readmission rates (P = .001).
• Administration of supplemental fluids (P = .001) and use of steroids (P = .005) were significantly reduced in the pathway group.
• No significant differences were observed in demographic factors, clinical severity, length of stay, or time in oxygen between the groups.

Conclusions:

• A clinical pathway for acute viral bronchiolitis can effectively reduce hospital readmissions.
• Implementing standardized guidelines and discharge criteria within a pathway minimizes inappropriate therapies.
• Clinical pathways aid in discharge planning and improve overall care for infants with bronchiolitis.